
Please try another search
genedrive plc is a United Kingdom-based commercial-stage molecular diagnostics business. The Company’s Genedrive device is a molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Company offers products, including Genedrive MT-RNR1 ID Kit and Genedrive COV19-ID Kit. The Company has two point-of-care tests on the market, which include Covid-19 and to help in the prevention of hearing loss caused by certain antibiotics in neonates. In addition, the Company also has assays on market for the detection of hepatitis c virus (HCV), certain military biological targets and a high throughput SARS-CoV-2 assay.
Name | Age | Since | Title |
---|---|---|---|
Ian David Gilham | 62 | 2014 | Independent Non-Executive Chairman |
Chris Henry Francis Yates | 47 | 2018 | Independent Non-Executive Director |
Thomas Lindsay | 62 | 2018 | Independent Non-Executive Director |
David Budd | 53 | 2016 | CEO & Executive Director |
Russell John Shaw | 43 | 2022 | Chief Financial Officer & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review